Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Quality of Care

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Statin Therapy for Patients with Diabetes

2017 HEDIS graph for Statin Therapy for Patients with Diabetes, VA average 81% and Non-VA average 65%

The graph above shows VA medical center scores compared with non-VA hospital scores for Statin Therapy for Patients with Diabetes. The percentages represent adults 40-75 years of age who have diabetes and who do not have clinical ASCVD, who received and adhered to statin therapy.  For this measure, a higher percentage indicates a higher quality of care, with 100 percent being the target.

What is this measure?
This measure is used to assess the percentage of adults 40-75 years of age who have diabetes and who do not have clinical ASCVD, who received and adhered to statin therapy.

What are we measuring?
The bar graph represents the percentage of adults 40-75 years of age who have diabetes and who do not have clinical ASCVD, who received and adhered to statin therapy.

Why is this important?
People with diabetes also have elevated cardiovascular risk, thought to be due in part to elevations in unhealthy cholesterol levels. Having unhealthy cholesterol levels places people at significant risk for developing ASCVD.

Statins are a class of drugs that lower blood cholesterol. American College of Cardiology and American Heart Association (ACC/AHA) guidelines state that statins of moderate or high intensity are recommended for adults with established clinical ASCVD. The American Diabetes Association and ACC/AHA guidelines also recommend statins for primary prevention of cardiovascular disease in patients with diabetes, based on age and other risk factors. Guidelines also state that adherence to statins will aid in ASCVD risk reduction in both populations.